10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine | CAS:3159-07-7
10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
- Name：10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
- CAS：3159-07-7
- Synonyms：11-Oxo-10,11-dihydro-Dibenzo[b,f][1,4]thiazepine
- Molecular Formula：C13H9NOS
- Molecular Weight：227.28
- EINESC：
Description
Properties
| 没有数据 | 没有数据 |
|---|
Safety
| 没有数据 | 没有数据 |
|---|
SDS
| Source | SDS/MSDS Samples |
|---|---|
| Sigma-Aldrich | View & Download |
| TCI | View & Download |
| Apollo | View & Download |
Synthetic Route
Articles
Peer-Reviewed Papers
α,ω-Functionalized Poly (2-Oxazoline) s Bearing Hydroxyl and Amino Functions.Reif M and Jordan R. Macromolecular Chemistry and Physics, 212(16), 1815-1824 (2011)
Molecular iodine-catalyzed facile procedure for N-Boc protection of amines.Ravi Varala et al.The Journal of organic chemistry, 71(21), 8283-8286 (2006-10-10)
Efficient copper-catalyzed cross-coupling of 1-Boc-piperazine with aryl iodides and its application in the synthesis of trazodone. Yong FF, et al. Tetrahedron Letters, 54(39), 5332-5334 (2013)
Inhibition of noroviruses by piperazine derivatives.Dengfeng Dou et al.Bioorganic & medicinal chemistry letters, 22(1), 377-379 (2011-11-29)
Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.Akihiko Tanitame et al.Bioorganic & medicinal chemistry letters, 14(11), 2857-2862 (2004-05-06)
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.Florencio Zaragoza et al.Journal of medicinal chemistry, 47(11), 2833-2838 (2004-05-14)
Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1H-benzo[d]imidazol-2(3H)-ones.Nisar Ullah Journal of enzyme inhibition and medicinal chemistry, 29(2), 281-291 (2013-03-16)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!